Invention Grant
US09226958B2 Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
有权
使用利斯特氏菌疫苗载体逆转疫苗在寄生虫感染个体中的反应性
- Patent Title: Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
- Patent Title (中): 使用利斯特氏菌疫苗载体逆转疫苗在寄生虫感染个体中的反应性
-
Application No.: US13876810Application Date: 2011-10-03
-
Publication No.: US09226958B2Publication Date: 2016-01-05
- Inventor: Donald A. Harn, Jr. , Yvonne Paterson , Lisa McEwen
- Applicant: Donald A. Harn, Jr. , Yvonne Paterson , Lisa McEwen
- Applicant Address: US GA Athens US PA Philadelphia
- Assignee: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.,THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Current Assignee: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.,THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Current Assignee Address: US GA Athens US PA Philadelphia
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- International Application: PCT/US2011/054613 WO 20111003
- International Announcement: WO2012/138377 WO 20121011
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K48/00 ; C12N15/00 ; A61K39/21 ; A61K39/12
Abstract:
This invention relates to methods of using a Listeria vaccine vector to induce a Th1 immune response in subjects having persistent Th2 immune response profiles.
Public/Granted literature
Information query
